ARTICLE | Finance
Mission: Mainstream
How Mission Bio plans to expand Tapestri’s reach with a $30M series B
December 14, 2018 8:56 PM UTC
Mission Bio Inc. plans to deploy its $30 million series B round to expand the applications and client base for its single-cell DNA analysis platform.
Agilent Technologies Inc. (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM Research Capital and Mayfield participated in the round, which closed on Dec. 13. ...
BCIQ Company Profiles